Alana Harris Dent

Array ( [id] => 4574206 [patent_doc_number] => 07829671 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-11-09 [patent_title] => 'Gene encoding a DNA repair enzyme and methods of use thereof' [patent_app_type] => utility [patent_app_number] => 12/354864 [patent_app_country] => US [patent_app_date] => 2009-01-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 44 [patent_figures_cnt] => 56 [patent_no_of_words] => 25416 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 44 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/829/07829671.pdf [firstpage_image] =>[orig_patent_app_number] => 12354864 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11388740 [patent_doc_number] => 09549971 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2017-01-24 [patent_title] => 'Methods for inhibiting angiogenesis using EGFL8 antagonists' [patent_app_type] => utility [patent_app_number] => 12/812944 [patent_app_country] => US [patent_app_date] => 2009-01-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 5 [patent_no_of_words] => 14863 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 125 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12812944 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6434158 [patent_doc_number] => 20100278849 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-11-04 [patent_title] => 'PROSTATIC ACID PHOSPHATASE ANTIGENS' [patent_app_type] => utility [patent_app_number] => 12/343013 [patent_app_country] => US [patent_app_date] => 2008-12-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 9325 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0278/20100278849.pdf [firstpage_image] =>[orig_patent_app_number] => 12343013 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5304100 [patent_doc_number] => 20090298752 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-12-03 [patent_title] => 'APLIDINE TREATMENT OF CANCERS' [patent_app_type] => utility [patent_app_number] => 12/342478 [patent_app_country] => US [patent_app_date] => 2008-12-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 9800 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0298/20090298752.pdf [firstpage_image] =>[orig_patent_app_number] => 12342478 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8421926 [patent_doc_number] => 08278414 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-10-02 [patent_title] => 'DNA sequence encoding a retinoic acid regulated protein' [patent_app_type] => utility [patent_app_number] => 12/339734 [patent_app_country] => US [patent_app_date] => 2008-12-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 10 [patent_no_of_words] => 5620 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12339734 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6235354 [patent_doc_number] => 20100267058 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-10-21 [patent_title] => 'CIRCULATING RET RECEPTOR' [patent_app_type] => utility [patent_app_number] => 12/808708 [patent_app_country] => US [patent_app_date] => 2008-12-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 8496 [patent_no_of_claims] => 44 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0267/20100267058.pdf [firstpage_image] =>[orig_patent_app_number] => 12808708 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8200925 [patent_doc_number] => 08188051 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-05-29 [patent_title] => 'Metadherin polypeptides, encoding nucleic acids and methods of use' [patent_app_type] => utility [patent_app_number] => 12/336409 [patent_app_country] => US [patent_app_date] => 2008-12-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 15 [patent_no_of_words] => 22879 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 73 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/188/08188051.pdf [firstpage_image] =>[orig_patent_app_number] => 12336409 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6615594 [patent_doc_number] => 20100310562 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-12-09 [patent_title] => 'SYSTEM FOR DELIVERY INTO XCR1 POSITIVE CELL AND USES THEREOF' [patent_app_type] => utility [patent_app_number] => 12/741798 [patent_app_country] => US [patent_app_date] => 2008-11-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 23736 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0310/20100310562.pdf [firstpage_image] =>[orig_patent_app_number] => 12741798 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7742072 [patent_doc_number] => 20120020878 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-01-26 [patent_title] => 'FUSOGENIC PROPERTIES OF SAPOSIN C AND RELATED PROTEINS AND PEPTIDES FOR APPLICATION TO TRANSMEMBRANE DRUG DELIVERY SYSTEMS' [patent_app_type] => utility [patent_app_number] => 13/127630 [patent_app_country] => US [patent_app_date] => 2008-11-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 45150 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0020/20120020878.pdf [firstpage_image] =>[orig_patent_app_number] => 13127630 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5270948 [patent_doc_number] => 20090074724 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-03-19 [patent_title] => 'MATERIALS AND METHODS FOR INHIBITING WIP1' [patent_app_type] => utility [patent_app_number] => 12/254513 [patent_app_country] => US [patent_app_date] => 2008-10-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 6450 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0074/20090074724.pdf [firstpage_image] =>[orig_patent_app_number] => 12254513 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5278063 [patent_doc_number] => 20090130195 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-05-21 [patent_title] => 'PROSTATE CARCINOGENESIS PREDICTOR' [patent_app_type] => utility [patent_app_number] => 12/253663 [patent_app_country] => US [patent_app_date] => 2008-10-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 44053 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0130/20090130195.pdf [firstpage_image] =>[orig_patent_app_number] => 12253663 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5563569 [patent_doc_number] => 20090136421 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-05-28 [patent_title] => 'PAI-2 conjugates for the treatment and imaging of cancer' [patent_app_type] => utility [patent_app_number] => 12/285767 [patent_app_country] => US [patent_app_date] => 2008-10-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 9550 [patent_no_of_claims] => 39 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0136/20090136421.pdf [firstpage_image] =>[orig_patent_app_number] => 12285767 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6187777 [patent_doc_number] => 20110171203 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-07-14 [patent_title] => 'METHODS FOR TREATING NEOPLASTIC DISEASE TARGETING O-LINKED N-ACETYLGLUCOSAMINE MODIFICATIONS OF CELLULAR PROTEIN' [patent_app_type] => utility [patent_app_number] => 12/679562 [patent_app_country] => US [patent_app_date] => 2008-10-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 13637 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0171/20110171203.pdf [firstpage_image] =>[orig_patent_app_number] => 12679562 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6493561 [patent_doc_number] => 20100209429 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-08-19 [patent_title] => 'PEPTIDES AND METHODS FOR THE TREATMENT OF GLIOMAS AND OTHER CANCERS' [patent_app_type] => utility [patent_app_number] => 12/678467 [patent_app_country] => US [patent_app_date] => 2008-09-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 12165 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0209/20100209429.pdf [firstpage_image] =>[orig_patent_app_number] => 12678467 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7662270 [patent_doc_number] => 20110311539 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-12-22 [patent_title] => 'DIAGNOSIS AND TREATMENT OF CANCER USING CANCER-TESTIS ANTIGENS' [patent_app_type] => utility [patent_app_number] => 12/678558 [patent_app_country] => US [patent_app_date] => 2008-09-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 31408 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 16 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0311/20110311539.pdf [firstpage_image] =>[orig_patent_app_number] => 12678558 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7662263 [patent_doc_number] => 20110311532 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-12-22 [patent_title] => 'INHIBITION OF COMPLEMENT AND CELLULAR ACTIVATION' [patent_app_type] => utility [patent_app_number] => 12/675906 [patent_app_country] => US [patent_app_date] => 2008-08-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 11167 [patent_no_of_claims] => 38 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0311/20110311532.pdf [firstpage_image] =>[orig_patent_app_number] => 12675906 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8701359 [patent_doc_number] => 08394580 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-03-12 [patent_title] => 'Protein markers for the detection of thyroid cancer metastasis' [patent_app_type] => utility [patent_app_number] => 12/222876 [patent_app_country] => US [patent_app_date] => 2008-08-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 9740 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 79 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12222876 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7724153 [patent_doc_number] => 08097423 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-01-17 [patent_title] => 'MN/CA IX and breast cancer therapy' [patent_app_type] => utility [patent_app_number] => 12/181951 [patent_app_country] => US [patent_app_date] => 2008-07-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 3 [patent_no_of_words] => 17967 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 108 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/097/08097423.pdf [firstpage_image] =>[orig_patent_app_number] => 12181951 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6320477 [patent_doc_number] => 20100196366 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-08-05 [patent_title] => 'Gefitnib Sensitivity-Related Gene Expression and Products and Methods Related Thereto' [patent_app_type] => utility [patent_app_number] => 12/670052 [patent_app_country] => US [patent_app_date] => 2008-07-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 35830 [patent_no_of_claims] => 93 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0196/20100196366.pdf [firstpage_image] =>[orig_patent_app_number] => 12670052 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8352050 [patent_doc_number] => 08247379 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-08-21 [patent_title] => 'Tumor associated amino acids and uses therefor' [patent_app_type] => utility [patent_app_number] => 12/175589 [patent_app_country] => US [patent_app_date] => 2008-07-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 23558 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 79 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12175589 [rel_patent_id] =>[rel_patent_doc_number] =>)